Allianz Global Investors Fund - Allianz Global Equity Unconstrained IT USDRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 15.1 | 18.8 | -16.9 | 23.6 | 2.3 | |
+/-Cat | -8.6 | 4.2 | 1.1 | 7.6 | -3.8 | |
+/-B’mrk | - | 0.7 | 2.0 | 1.3 | -4.8 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 16/05/2024 | USD 2401.23 | |
Day Change | 1.06% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | LU1377962367 | |
Fund Size (Mil) 03/01/2024 | EUR 472.55 | |
Share Class Size (Mil) 16/05/2024 | USD 40.26 | |
Max Initial Charge | 2.00% | |
Ongoing Charge 16/02/2024 | 1.09% |
Investment Objective: Allianz Global Investors Fund - Allianz Global Equity Unconstrained IT USD |
Long-term capital growth by investing in global equity markets to achieve a concentrated equity portfolio with a focus on stock selection. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Tobias Kohls 01/02/2021 | ||
Christian Schneider 19/12/2008 | ||
Inception Date 17/05/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR EUR | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Global Equity Unconstrained IT USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Corpay Inc | Technology | 4.58 |
Thermo Fisher Scientific Inc | Healthcare | 4.38 |
Assa Abloy AB Class B | Industrials | 4.14 |
Roper Technologies Inc | Technology | 4.14 |
Visa Inc Class A | Financial Services | 4.11 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Global Equity Unconstrained IT USD |